期刊
JOURNAL OF IMMUNOLOGY
卷 192, 期 12, 页码 6037-6044出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1302296
关键词
-
类别
资金
- Swiss National Science Foundation [31003A138484, 320030-130243]
- Novartis Foundation [09C53]
- Deutsche Forschungsgemeinschaft [LA 2806/1-1, LA 2806/2-1]
- Johann Wolfgang Goethe University
Recent clinical research suggests a role for vitamin D in the response to IFN-alpha-based therapy of chronic hepatitis C. Therefore, we aimed to explore the underlying mechanisms in vitro. Huh-7.5 cells harboring subgenomic hepatitis C virus (HCV) replicons or infected with cell culture-derived HCV were exposed to bioactive 1,25-dihydroxyvitamin D-3 (calcitriol) with or without IFN-alpha. In these experiments, calcitriol alone had no effect on the HCV life cycle. However, calcitriol enhanced the inhibitory effect of IFN-alpha on HCV replication. This effect was based on a calcitriol-mediated increase of IFN-alpha-induced gene expression. Further mechanistic studies revealed a constitutive inhibitory interaction between the inactive vitamin D receptor (VDR) and Stat1, which was released upon stimulation with calcitriol and IFN-alpha. As a consequence, IFN-alpha-induced binding of phosphorylated Stat1 to its DNA target sequences was enhanced by calcitriol. Importantly, and in line with these observations, silencing of the VDR resulted in an enhanced hepatocellular response to IFN-alpha. Our findings identify the VDR as a novel suppressor of IFN-alpha-induced signaling through the Jak-STAT pathway.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据